stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Free cash flow margin
Pulse Biosciences, Inc's free cash flow margin over the twelve months to 30 September 2026 was −14,462.5%, up 1096.6 percentage points from fiscal 2025 (−15,559.1%). Over the past ten years it has ranged from −15,559.1% (fiscal 2025) to 0.00% (fiscal 2024) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 2.36% and below the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | −15,559.1% | (15,559.14) |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | 6,773.43 |
| FY2022 | −6,773.4% | (2,927.59) |
| FY2021 | −3,845.8% | (3,845.84) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | 0.00 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| MMSI Merit Medical Systems, Inc. compare | 14.0% |
| ICUI ICU Medical, Inc. compare | 12.5% |
| ATRC AtriCure, Inc. compare | 8.98% |
| NVST Envista Holdings Corporation compare | 8.50% |
| TFX Teleflex Incorporated compare | 2.36% |
| WRBY Warby Parker Inc. compare | 2.28% |
| STVN Stevanato Group S.p.A. compare | −0.61% |
| MMED MiniMed Group, Inc. compare | −14.9% |
| PLSE Pulse Biosciences, Inc | −14,462.5% |
| Medical Instruments & Supplies industry median | 2.36% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement